Sawai Pharma Of Japan to Propose Merger With Kyorin Holdings
This article was originally published in PharmAsia News
Executive Summary
Japan's Sawai Pharmaceutical said it plans to propose a merger with Kyorin Holdings to combine their expertise in producing generic and innovative drugs